rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2 Suppl
|
pubmed:dateCreated |
1994-8-4
|
pubmed:abstractText |
Photorefractive keratectomy (PRK) requires a careful pharmacologic regimen during the postoperative period to reduce corneal haze and refractive myopic regression. Noncorticosteroidal anti-inflammatory drugs limit postablative corneal inflammation without the complications that may occur during corticosteroid treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1081-0803
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S287-9
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7517321-Administration, Topical,
pubmed-meshheading:7517321-Cornea,
pubmed-meshheading:7517321-Dexamethasone,
pubmed-meshheading:7517321-Diclofenac,
pubmed-meshheading:7517321-Follow-Up Studies,
pubmed-meshheading:7517321-Humans,
pubmed-meshheading:7517321-Laser Therapy,
pubmed-meshheading:7517321-Myopia,
pubmed-meshheading:7517321-Ophthalmic Solutions,
pubmed-meshheading:7517321-Postoperative Complications,
pubmed-meshheading:7517321-Refraction, Ocular,
pubmed-meshheading:7517321-Visual Acuity
|
pubmed:articleTitle |
Use of topical nonsteroidal anti-inflammatory drugs after photorefractive keratectomy.
|
pubmed:affiliation |
Resnati S. Raffaele Hospital Eye Clinic, Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|